MARSHALL WACE, LLP - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 153 filers reported holding ENDOLOGIX INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$85,000
-82.1%
118,383
-52.5%
0.00%
-50.0%
Q3 2018$476,000
-74.6%
249,458
-23.8%
0.00%
-83.3%
Q4 2016$1,872,000
+123.1%
327,301
+399.1%
0.01%
+100.0%
Q3 2016$839,000
-64.6%
65,576
-76.9%
0.01%
-73.9%
Q1 2016$2,373,000
+693.6%
283,797
+840.8%
0.02%
+666.7%
Q4 2015$299,000
+74.9%
30,167
+170.1%
0.00%
+50.0%
Q4 2014$171,00011,1700.00%
Other shareholders
ENDOLOGIX INC shareholders Q3 2016
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$49,653,0005.91%
Essex Woodlands Management, Inc. 1,257,468$21,220,0003.88%
PURA VIDA INVESTMENTS, LLC 205,100$2,515,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,347,113$28,776,0001.11%
First Light Asset Management, LLC 180,963$2,219,0001.10%
ArrowMark Colorado Holdings LLC 2,889,546$35,426,0000.97%
PALISADE CAPITAL MANAGEMENT, LP 2,149,949$26,358,0000.78%
Iguana Healthcare Management, LLC 150,000$1,839,0000.72%
CADIAN CAPITAL MANAGEMENT, LP 1,492,443$18,297,0000.66%
WASHINGTON CAPITAL MANAGEMENT, INC 85,882$1,053,0000.66%
View complete list of ENDOLOGIX INC shareholders